Peggy A Callahan, MD | |
8901 W Lincoln Ave, Hyperbaric Medicine And Wound Care, West Allis, WI 53227-2409 | |
(414) 203-3760 | |
Not Available |
Full Name | Peggy A Callahan |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 8901 W Lincoln Ave, West Allis, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093732661 | NPI | - | NPPES |
32201200 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 37393 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Peggy A Callahan, MD 8901 W Lincoln Ave, Hyperbaric Medicine And Wound Care, West Allis, WI 53227-2409 Ph: (414) 203-3760 | Peggy A Callahan, MD 8901 W Lincoln Ave, Hyperbaric Medicine And Wound Care, West Allis, WI 53227-2409 Ph: (414) 203-3760 |
News Archive
Our public health organizations strongly support the bipartisan legislation introduced today in both the House and Senate to provide the U.S. Food and Drug Administration (FDA) with effective authority to regulate tobacco products.
Researchers at The University of Western Ontario have discovered a strategy for stimulating the formation of highly functional new blood vessels in tissues that are starved of oxygen. Dr. Geoffrey Pickering and Matthew Frontini at the Schulich School of Medicine & Dentistry developed a strategy in which a biological factor, called fibroblast growth factor 9, is delivered at the same time that the body is making its own effort at forming new blood vessels in vulnerable or damaged tissue.
As scientists race to discover new and effective antiviral drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many novel approaches are being utilized. Now, a new study published on the preprint bioRxiv in September 2020 reports on the discovery of a potentially beneficial enzyme blocker that could inhibit SARS-CoV-2 viral replication.
Researchers at the University of Huddersfield have warned there is an urgent need for the country's mental health interventions to create strategies optimizing the use of antidepressants after conducting a study which has highlighted an alarming rise in relation to usage and costs.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
› Verified 9 days ago
William Nicholson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2514 S 102nd St Ste 160, West Allis, WI 53227 Phone: 414-255-0300 Fax: 414-543-9601 | |
Michael D Hazelberg, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2514 S 102nd St Ste 160, West Allis, WI 53227 Phone: 414-255-0300 Fax: 414-543-9601 | |
Gregory Rachu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7220 W National Ave, West Allis, WI 53214 Phone: 414-257-8500 | |
Dr. Paul Gordon Malen, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2323 S 109th St, #220, West Allis, WI 53227 Phone: 414-541-5222 Fax: 414-541-4959 | |
Hillary A Tamar, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 | |
Francis X Ruzicka, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S 70th St, West Allis, WI 53214 Phone: 414-773-6600 Fax: 414-773-6672 |